Mako Surgical posts Q3 revenue jump; Russia looks to reform medical device regulations;

 @FierceMedDev: Theragenics faced slumping revenue in Q3. The device maker blames hc reform, the device tax and economic uncertainty. More | Follow @FierceMedDev

 @MarkHFierce: OraSure's new HIV rapid Dx test helped reduce losses in Q3. News | Follow @MarkHFierce

 @DamianFierce: Boston Sci is now a hypertension player, spending $425M on Vessix, a Fierce 15 winner. More | Follow @DamianFierce

> Mako Surgical ($MAKO), a surgical robot maker, boosted revenue and reduced losses in its 2012 third quarter. Story

> Critical Diagnostics says a new study shows its ST2 assay is highly accurate in predicting the risk of heart failure and death in the general population. Item

> Health care supplier Novation submitted comments to the FDA backing a rapid implementation of a unique device identification system for medical devices. Release

> Vision Care won its Health Canada license to market an implantable telescope prosthesis for end-stage macular degeneration. Item

> OraSure Technologies narrowed its quarterly loss by $1.5 million in Q3, predicting a bigger fourth quarter after getting FDA approval for its at-home HIV diagnostic. Article

> A patient was able to climb 103 floors of Chicago's Willis Tower using a neutrally controlled, powered prosthetic limb being developed by Freedom Innovations. Release

> Updated Russian medical device regulations will launch in early 2013, but their implementation remains under question. Item

Biotech News

 @FierceBiotech: After cashing in on life-saving boast, biotech stayed mum on patient death. Story | Follow @FierceBiotech

 @JohnCFierce: Catalyst $CPRX cocaine addiction drug flops in phase IIb, shares down 65%--a penny stock now. More | Follow @JohnCFierce

 @RyanMFierce: GNS Healthcare, Mt. Sinai and Farber want to drop a Big Data bomb on cancer with a computer model of mult. myeloma. Release | Follow @RyanMFierce

> FDA experts give Novartis' Cushing's drug unanimous endorsement. Story

> BioCryst scraps $235M late-stage flu drug program backed by feds. Article

> Novartis R&D spotlights blockbuster hopefuls, promises 14 big approvals. News

Pharma News

@FiercePharma: Will Merck's Oxytrol benefit from new FDA interest in OTC access? More | Follow @FiercePharma

> GSK, XenoPort part ways after Horizant disappointment. Article

> Sun joins dermatology rush with $230M Dusa buyout. News

> Long-term study reinforces safety record of blockbuster Pradaxa. Story

Vaccine News

 @AlisonBFierce: The percentage of drug-resistant malaria cases is on the rise in Southeast Asia, a cause for concern among experts. News | Follow @AlisonBFierce

> GSK withdraws infant vaccine in Canada. Article

> BiondVax, MonoSol Rx develop oral universal flu vaccine. News

> Scripps researchers develop methamphetamine vaccine. Story

> PsiOxus lands $2.7M for ovarian cancer vaccine trial. Item

Pharma Manufacturing News

> African raids seize 82M doses of counterfeits. Report

> Another online seller of fake Viagra heads for jail. Story

> Hospira slowly ramps up production. Article

> GlaxoSmithKline pulls vaccines after bacteria found in plant. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.